Understanding how a fungus called Cryptococcus neoformans produces melanin
The biology of Cryptococcus neoformans melanization
This study is looking at how a fungus called Cryptococcus neoformans, which can be dangerous for people with weakened immune systems, makes a protective pigment called melanin that makes it tougher to treat with medications, and it aims to discover new ways to fight these infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11015834 on NIH RePORTER |
What this research studies
This research investigates the biology of Cryptococcus neoformans, a fungal pathogen that poses a significant risk to immunosuppressed individuals. It focuses on how this fungus produces melanin, a pigment that not only protects the fungus but also makes it harder to treat with antifungal medications. The study employs a multidisciplinary approach, utilizing biochemical, cell biology, and advanced spectroscopic techniques to explore the mechanisms behind melanin production and its effects on the immune response. By identifying how melanin is exported and its role in interactions with immune cells, the research aims to find new ways to combat fungal infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are immunocompromised, such as those living with HIV/AIDS or undergoing immunosuppressive therapies.
Not a fit: Patients with fungal infections who are not immunocompromised may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance the effectiveness of antifungal therapies for patients with serious fungal infections.
How similar studies have performed: Previous research has shown promising results in understanding fungal pathogens and their resistance mechanisms, indicating that this approach could yield valuable insights.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Casadevall, Arturo — Johns Hopkins University
- Study coordinator: Casadevall, Arturo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.